实验方案(Protocols)

Recombinant Human HEPACAM Protein: Protocol & Usage Guide

Recombinant Human HEPACAM Protein is a purified recombinant form of the hepatocyte cell adhesion molecule used in a broad range of in vitro studies investigating cell adhesion, glioma biology, and neurological disease mechanisms.

Product Name
Recombinant Human HEPACAM Protein
SKU
rp365282
Protein Origin
Human (Homo sapiens)
Protein Type
Recombinant, cell adhesion molecule (IgSF family)
Primary Applications
ELISA, cell-based assays, binding studies, Western blot
Storage Recommendation
Avoid repeated freeze-thaw cycles; aliquot upon reconstitution

Background: HEPACAM Protein Biology

HEPACAM (Hepatocyte Cell Adhesion Molecule), also known as GlialCAM, is a type I transmembrane glycoprotein belonging to the immunoglobulin superfamily (IgSF). It was originally identified in hepatocytes and subsequently found to be highly expressed in glial cells of the central nervous system (CNS). HEPACAM plays important roles in cell–cell adhesion, cell migration, and the regulation of membrane protein localization, particularly in astrocytes.

Mutations in the HEPACAM gene have been associated with megalencephalic leukoencephalopathy with subcortical cysts (MLC), a rare inherited white matter disorder. Additionally, HEPACAM has been studied as a candidate tumor suppressor in hepatocellular carcinoma and glioma. Recombinant Human HEPACAM Protein enables researchers to perform controlled in vitro experiments, characterize receptor interactions, and develop potential therapeutic strategies.

Materials and Equipment Required

Before beginning reconstitution and experimental use of Recombinant Human HEPACAM Protein (rp365282), ensure the following materials and equipment are available:

  • Recombinant Human HEPACAM Protein (Aladdin SKU: rp365282)
  • Sterile phosphate-buffered saline (PBS, pH 7.4) or manufacturer-specified reconstitution buffer
  • Sterile deionized water (if specified by product datasheet)
  • Low-protein-binding microcentrifuge tubes (1.5 mL)
  • Calibrated micropipettes and sterile tips
  • Refrigerated microcentrifuge
  • -20°C or -80°C freezer for long-term storage
  • Protein quantification reagents (e.g., BCA or Bradford assay kit)
  • Appropriate ELISA plates, cell culture plates, or gel electrophoresis apparatus depending on downstream assay

Note: Always consult the official product datasheet supplied with SKU rp365282 for the most accurate and up-to-date specifications prior to use.

Step-by-Step Reconstitution and Handling Protocol

Follow the steps below to reconstitute and handle Recombinant Human HEPACAM Protein correctly and safely:

  1. Equilibrate the vial: Remove the protein vial from storage and allow it to equilibrate to room temperature for approximately 10–15 minutes before opening. Do not expose the lyophilized protein to direct heat sources.
  2. Prepare reconstitution buffer: Use sterile PBS (pH 7.4) or the buffer specified in the product datasheet for rp365282. Ensure the buffer is at room temperature prior to addition.
  3. Reconstitute: Add the appropriate volume of reconstitution buffer to the vial as directed by the datasheet to achieve the recommended stock concentration. Gently swirl or pipette to mix — do not vortex, as this may denature the protein.
  4. Centrifuge briefly: Spin the vial at low speed (e.g., 500–1000 × g for 30 seconds) to collect any residual protein from the walls and cap of the vial.
  5. Verify dissolution: Inspect the solution for clarity. If particulates are observed, allow the vial to stand for an additional 5 minutes and mix gently again.
  6. Quantify protein concentration: Confirm the actual protein concentration using a BCA or Bradford assay to ensure consistency across experiments.
  7. Aliquot immediately: Divide the reconstituted protein into single-use aliquots in low-protein-binding tubes to prevent repeated freeze-thaw cycles, which can degrade activity.
  8. Store appropriately: Store aliquots at -20°C for short-term use (up to 1 month) or at -80°C for long-term storage. Refer to the product datasheet for specific stability data.

Important: Avoid repeated freeze-thaw cycles. Each cycle may reduce protein activity and compromise experimental reproducibility.

Troubleshooting and Quality Control

If unexpected results are obtained when using Recombinant Human HEPACAM Protein, consider the following troubleshooting guidance:

  • No or weak signal in ELISA/Western blot: Verify protein concentration by BCA assay. Check that the protein was fully dissolved and not aggregated. Confirm compatibility of detection antibody with the recombinant protein construct.
  • Protein aggregation or precipitation: Ensure reconstitution buffer pH and ionic strength are appropriate. Avoid vortexing. If aggregation persists, briefly centrifuge at 10,000 × g for 5 minutes and use supernatant.
  • Loss of biological activity: Confirm that the protein has not undergone more than one freeze-thaw cycle. Check storage temperature and duration against product datasheet specifications.
  • Inconsistent results between experiments: Always use freshly thawed aliquots. Standardize protein quantification method across experiments. Ensure all reagents and buffers are within their expiry dates.
  • Unexpected molecular weight on SDS-PAGE: HEPACAM is a glycoprotein; apparent molecular weight on denaturing gels may differ from the calculated molecular weight due to glycosylation. This is expected and not indicative of product quality issues.

For additional technical support, contact Aladdin Scientific's technical service team with your order number and lot number.

Frequently asked questions

What is HEPACAM and why is it important in research?

HEPACAM (Hepatocyte Cell Adhesion Molecule), also called GlialCAM, is an IgSF transmembrane glycoprotein involved in cell adhesion, glial cell biology, and CNS development. It is clinically relevant due to its association with megalencephalic leukoencephalopathy with subcortical cysts (MLC) and its role as a putative tumor suppressor in hepatocellular carcinoma and glioma, making it a key target in neurological disease and oncology research.

How should Recombinant Human HEPACAM Protein (rp365282) be stored after reconstitution?

After reconstitution, the protein should be immediately aliquoted into single-use volumes using low-protein-binding tubes to minimize freeze-thaw cycles. Short-term aliquots can be stored at -20°C for up to approximately one month, while long-term storage is recommended at -80°C. Always consult the official product datasheet for lot-specific stability data.

Can Recombinant Human HEPACAM Protein be used as a positive control in Western blot experiments?

Yes, Recombinant Human HEPACAM Protein (rp365282) can serve as a positive control in Western blot assays. A typical loading amount falls in the range of 50–200 ng per lane, though this should be optimized based on the sensitivity of your detection system. Note that the apparent molecular weight on denaturing SDS-PAGE may differ from the theoretical value due to glycosylation of the native protein.

Why might I observe a different molecular weight than expected on SDS-PAGE for HEPACAM?

HEPACAM is a glycoprotein, and post-translational glycosylation adds additional mass beyond the protein backbone, causing the apparent molecular weight on SDS-PAGE to exceed the theoretically calculated value. This is a normal characteristic of glycoproteins and does not indicate a product quality issue. If in doubt, confirm identity by mass spectrometry or with a validated antibody.

What applications is Recombinant Human HEPACAM Protein (rp365282) validated for?

Recombinant Human HEPACAM Protein is generally suitable for ELISA, cell-based adhesion assays, binding and interaction studies, and Western blot as a positive control. For a definitive list of validated applications and confirmed performance data specific to lot rp365282, please refer to the product datasheet provided by Aladdin Scientific.

References

  1. Lopez-Hernandez T, et al. Mutant GlialCAM causes megalencephalic leukoencephalopathy with subcortical cysts, benign familial macrocephaly, and macrocephaly with retardation and autism. American Journal of Human Genetics. 2011.
  2. Favre-Kontula L, et al. GlialCAM, an immunoglobulin-like cell adhesion molecule is expressed in glial cells of the central nervous system. Glia. 2008.
  3. Moh MC, et al. HEPACAM, a novel immunoglobulin-like cell adhesion molecule, suppresses tumor growth in vivo. Hepatology. 2005.

Products are supplied for research and development use only. Not for use in humans, animals, diagnosis, or therapy.

目录: 实验方案(Protocols)

Da — 若无特别说明,分子量单位默认为道尔顿。   Mw — 重均分子量。   Mn — 数均分子量。

产品仅供科研与开发使用,不用于人体、动物、诊断或治疗。

引用本文

阿拉丁科学.《Recombinant Human HEPACAM Protein: Protocol & Usage Guide》. 阿拉丁知识库,更新于 2026年11月2日。 https://www.aladdin-e.com/zh_cn/faqs/recombinant-human-hepacam-protein-protocol-en.html
这篇文章对您有帮助吗? Yes No 有 0 人觉得有帮助